Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex OLE in advanced cancer pain
NCT01337089Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jan 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 18
01
Overview
Phase 3, open-label, single-arm trial of cannabis extract in cancer pain, sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Percent Of Participants With Treatment-emergent Adverse Events at Day 183. Started Jan 2011; status: completed.
02
Drugs
cannabis extract
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01337089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01337089.